Literature DB >> 459524

Survival with residual tumor on the bronchial margin after resection for bronchogenic carcinoma.

A S Soorae, H M Stevenson.   

Abstract

Sixty-four (14.7 percent) of 434 consecutive patients having pulmonary resection for bronchogenic carcinoma were found to have microscopic residual tumor on the cut margins of the resected specimens. These subjects were further subdivided histologically into those with direct extension of the tumor (34 patients), lymphatic permeation (14 patients), clumps of cancer cells in parabronchial tissues (six patients), and the presence of carcinoma in situ change (10 patients). Bronchopleural fistulas developed in eight (12.5 percent) of 64 patients. The operative mortality rate was 15.6 percent, with four of the deaths occurring as the result of bronchopleural fistulas. Thirty-two patients (50 percent) survived 1 year, 21 (32.8 percent) survived 3 years, and 15 (23.4 percent) lived for 5 years or more. The patients with tumor in the submucosal and peribronchial lymphatics had the worst prognosis. 78.6 percent having died within 1 year and the remainder within 3 years. All 5-year survivors were men with squamous cell carcinoma and had relatively small tumors (mean diameter 2.9 cm). No direct relationship between the length of the resected bronchial stump and survival could be established; a short stump did not preclude long survival. The possible factors involved in the relatively high 5 year survival rate in this group of patients and the therapeutic implications of these factors are discussed.

Entities:  

Mesh:

Year:  1979        PMID: 459524

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  Intraoperative near-infrared fluorescence imaging targeting folate receptors identifies lung cancer in a large-animal model.

Authors:  Jane J Keating; Jeffrey J Runge; Sunil Singhal; Sarah Nims; Ollin Venegas; Amy C Durham; Gary Swain; Shuming Nie; Philip S Low; David E Holt
Journal:  Cancer       Date:  2016-11-07       Impact factor: 6.860

Review 2.  [Indications and limitations of fresh frozen sections in the pulmonary apparatus].

Authors:  K Pütz; M Engels; C Vollbrecht; L C Heukamp; A C Adam; R Büttner
Journal:  Pathologe       Date:  2012-09       Impact factor: 1.011

3.  Autologous x-irradiated tumour cells and percutaneous BCG in operable lung cancer.

Authors:  B H Stack; N McSwan; J M Stirling; D J Hole; W G Spilg; I McHattie; J A Elliott; C R Gillis; M A Turner; R G White
Journal:  Thorax       Date:  1982-08       Impact factor: 9.139

4.  Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.

Authors:  Raymond U Osarogiagbon; Chun Chieh Lin; Matthew P Smeltzer; Ahmedin Jemal
Journal:  J Thorac Oncol       Date:  2016-01       Impact factor: 15.609

5.  Implications of histologically reported residual tumour on the bronchial margin after resection for bronchial carcinoma.

Authors:  M R Law; M E Hodson; S C Lennox
Journal:  Thorax       Date:  1982-07       Impact factor: 9.139

6.  Cardiac tamponade as a presenting symptom of bronchial carcinoma.

Authors:  S R Cunningham; C F Stanford; M M Khan; W P Abram
Journal:  Ulster Med J       Date:  1987-04

7.  Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical margins.

Authors:  Meng Yuan; Yu Men; Jingjing Kang; Xin Sun; Maoyuan Zhao; Yongxing Bao; Xu Yang; Shuang Sun; Zeliang Ma; Jianyang Wang; Lei Deng; Wenqing Wang; Yirui Zhai; Wenyang Liu; Tao Zhang; Xin Wang; Nan Bi; Jima Lv; Jun Liang; Qinfu Feng; Dongfu Chen; Zefen Xiao; Zongmei Zhou; Luhua Wang; Zhouguang Hui
Journal:  Thorac Cancer       Date:  2020-11-27       Impact factor: 3.223

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.